Aitia Email Format
Biotechnology ResearchMassachusetts, United States51-200 Employees
Aitia is a biotechnology research company based in Cambridge, Massachusetts, focused on integrating multiomic patient data, high-performance computing, and causal learning to map the complex circuitry of human biology. Its work centers on identifying novel disease targets and enabling focused patient recruitment for clinical development, with a goal of accelerating the next generation of therapies through computational representations of disease, referred to as Gemini Digital Twins. The firm partners with pharmaceutical companies to translate these discoveries into therapeutic development, leveraging in silico patient models to simulate treatment at the individual level. The company operates within the broader field of biopharmaceutical analytics and precision medicine, aiming to provide deeper biological insight and more efficient clinical progression for drug candidates. Aitia has engaged in collaborations and leadership roles within the industry, including notable partnerships and leadership appointments as part of its recent activity.